CD44 and breast carcinoma: However, Ryoo et al. [48] reported that the molecular mechanisms of CD44-mediated NRF2 activation involve high p62 expression and that high levels of CD44 lead to p62-associated NRF2 activation in CD44high breast cancer stem cell (CSC)-like cells.